Perfiby Announces Innovative New Supplements to Address Wide Range of Consumer Health Issues
CALIFORNIA CITY, CA / ACCESSWIRE / September 23, 2024 / Perfidy has just released a range of new natural help...
News
Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs’ Mpox PCR Detection Kits
CHICAGO, IL / ACCESSWIRE / September 23, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren’s Syndrome, a Rare Disease With Limited Treatment Options
Prior Phase 3 studies showed positive benefits in increasing unstimulated whole saliva secretionAinos aims to complete all regulatory approvals for...
Glocal Cannabis Nursing Institute (GCNI) Expands Horizons: A Comprehensive Approach to Interprofessional Cannabis Education, Clinical Practicums, Research, and Advocacy Leading to International Research, Practice and Employment Opportunities in Global Cannabis Nursing
The Institute's Collaborative Model with the Center for Incubation & Findings Research (CIFR) and Compassion Center Sets the Stage for...
Avant Brands Expands Global Footprint with BLK MKT(TM) Launch in Australia
KELOWNA, BC and MELBOURNE, AUSTRALIA / ACCESSWIRE / September 23, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"),...
Science & Humans Proudly Welcomes Renowned Healthcare Leader Karim “Matt” Nassar as Chief Growth Officer
MISSISSAUGA, ON / ACCESSWIRE / September 23, 2024 / Science & Humans (S&H), Canada's leading platform for hormone health, is...
Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System
New System Enhances Surgical Efficiency and Provides Versatile Solutions for Complex Spine ProceduresBELGRADE, MT / ACCESSWIRE / September 23, 2024...
Dyne Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference
WALTHAM, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on...
Kronos Bio Highlights Data at AACR Ovarian Cancer Research Symposium that Supports Clinical Evaluation of Istisociclib in Advanced Ovarian Cancer
– New data show istisociclib (KB-0742) triggered cell death in preclinical ovarian cancer models of platinum and PARP-inhibitor (PARPi) resistance –...
Jackson Health System projects 47% reduction in carbon emissions from patient monitors with Philips next generation monitoring platform
Jackson Memorial Health System Philips MX550 IntelliVue Portable Bedside Patient Monitor with Shield Philips MX750, MX850, IntelliVue, Patient Monitors with...
Interim Results for the Six Months Ended 30 June 2024
Press release OXFORD BIOMEDICA PLCINTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024 Delivering Pure-Play CDMO Growth Strategy Continued...
Revolutionizing Surgery: SS Innovations International Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System
FORT LAUDERDALE, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII),...
Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on October 2
MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global...
Cerevance to Participate in a Panel Discussion at Fierce Biotech Summit 2024
BOSTON, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system...
SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome Treatment
FDA confirms that SciSparc’s study may proceed following the application submission a month ago TEL AVIV, Israel, Sept. 23, 2024...
Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza
The Phase 2b trial will enroll 5,000 subjects across clinical sites in the US and UKSAN DIEGO, Sept. 23, 2024...
Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress
Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for...
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement Paris, France, September 23, 2024, 2:00 pm CET...
Elevar Therapeutics Resubmits New Drug Application to FDA for Combination of Camrelizumab plus Rivoceranib as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma Boosted by CARES-310 Leading Overall Survival Analysis
FORT LEE, N.J., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd., today...
Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
GARDEN CITY, N.Y., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a...